Every open market buy and sale of Eton Pharmaceuticals, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $31M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when ETON insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an ETON officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every ETON insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | Ipek Erdogan-TrinkausChief Commercial Officer | Sale | 3,500 | $67.41 | $236K | 4,081 | Nov 12Form 4 |
| Nov 10, 2026 | Charles J CasamentoDirector | Sale | 80,555 | $66.35 | $5.3M | 0 | Nov 10Form 4 |
| Oct 6, 2026 | David KrempaChief Business Officer | Sale | 4,166 | $55.07 | $229K | 43,381 | Oct 6Form 4 |
| Aug 28, 2026 | Paul V MaierDirector | Sale | 50,000 | $59.07 | $3M | 59,745 | Aug 28Form 4 |
| Aug 24, 2026 | David KrempaChief Business Officer | Sale | 25,000 | $65.07 | $1.6M | 37,025 | Aug 24Form 4 |
| Aug 20, 2026 | Sean BrynjelsenPresident & CEO | Sale | 100,000 | $60.88 | $6.1M | 961,194 | Aug 20Form 4 |
| Jul 14, 2026 | Opaleye Management Inc.10% owner | Sale | 28,315 | $37.54 | $1.1M | 40,000 | Jul 16Form 4 |
| Jul 7, 2026 | Opaleye Management Inc.10% owner | Sale | 126,685 | $37.64 | $4.8M | 53,315 | Jul 7Form 4 |
| Jun 17, 2026 | Jennifer McKie AdamsDirector | Sale | 50,000 | $32.48 | $1.6M | 0 | Jun 17Form 4 |
| May 28, 2026 | Sean BrynjelsenPresident & CEO | Sale | 120,000 | $31.88 | $3.8M | 833,694 | May 29Form 4 |
| May 27, 2026 | David KrempaChief Business Officer | Sale | 100,000 | $32.30 | $3.2M | 25,249 | May 27Form 4 |
| Aug 20, 2025 | James R. GruberCFO | Sale | 41,713 | $16.15 | $674K | 204,753 | Aug 20Form 4 |
| Jun 16, 2025 | David KrempaChief Business Officer | Sale | 34,000 | $14.83 | $504K | 612,646 | Jun 16Form 4 |
| Jun 10, 2025 | Opaleye Management Inc.10% owner | Buy | 7,930 | $15.82 | $125K | 85,000 | Jun 12Form 4 |
| Jun 5, 2025 | Sean BrynjelsenPresident & CEO | Sale | 210,000 | $17.11 | $3.6M | 2,873,513 | Jun 5Form 4 |
ETON insider trading FAQ
Are ETON insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of ETON on the open market in 0 trades, and 7 sold $31M in 11 trades.
When did an ETON insider last buy shares?
Opaleye Management Inc. (10% owner) bought 7,930 shares for $125K on Jun 10, 2025, reported on Jun 12, 2025.
When did an ETON insider last sell shares?
Ipek Erdogan-Trinkaus (Chief Commercial Officer) sold 3,500 shares for $236K on Nov 10, 2026.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
